• Successful $609,000 capital raise through private placement
• Progressed Indonesian seaweed business with new operations, supply agreements, and R&D
• Entered into blockchain technology partnership to enhance traceability and carbon credits

BPH Global Limited (ASX: BP8), a plant-based biotechnology company, released its Appendix 4C and Quarterly Activities Report for the period ended 31 March 2025. During the quarter, the company maintained strong engagement with prospective investors, culminating in a successful $609,000 (before costs) capital raise through the issue of 304,500,000 fully paid ordinary shares. The funds will be used to support the company's business development efforts. Key developments in the company's Indonesian seaweed operations included the completion of an agreement with joint venture partners, the registration of a wholly-owned subsidiary, the establishment of operational infrastructure, and the signing of seaweed supply agreements with buyers in Indonesia and China. The company also announced a consulting agreement with Temasek Polytechnic in Singapore to study the mineral content of seaweed grown in polluted waters, with promising initial results. Additionally, the company entered into a partnership with blockchain technology provider #dltledgers to enhance the traceability and carbon sequestration measurement of its seaweed business.

The company will continue to focus on growing its seaweed business in Indonesia, including expanding its supply chain, securing additional offtake agreements, and progressing its R&D efforts to extract valuable minerals and chemicals from seaweed. The successful capital raise provides the company with the necessary funding to execute on its strategic initiatives.